Skip to content

Improving Metabolism With HDL Cholesterol

A Novel Mechanism Mediating Anti-atherosclerotic and Metabolic Actions of HDL Cholesterol

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00395148
Enrollment
13
Registered
2006-11-02
Start date
2006-03-31
Completion date
2008-03-31
Last updated
2011-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Heart Disease

Brief summary

High levels of good cholesterol (HDL) in our blood decreases our chance of having a heart attack. This relates in part to the role good cholesterol plays in reducing build up of fat in the arteries. However, good cholesterol has many other protective effects. We have recently identified three enzymes (proteins) activated by HDL in cells lining the blood vessels, which may be responsible for some of HDL's protective actions.

Interventions

DRUGrHDL

Sponsors

Baker Heart Research Institute
CollaboratorOTHER
Bayside Health
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18 - 65 years * Free of overt coronary disease * Body mass index \<35 kg.m-2 * Fasting plasma glucose \> 7 mmol/L-1 * No major illness

Exclusion criteria

* Unable to give informed consent * Smokers * Abnormal LFT, U&E, FBE or creatinine

Design outcomes

Primary

MeasureTime frame
Metabolic parameters

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026